Here are the 10-Q quarterly reports from ChronoScale Holdings Corporation (CHRN) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CHRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CHRN filings page.
ChronoScale Holdings Corp. (CHRN) reported revenue of $41.482 million for the three months ended August 31, 2026, versus $16.718 million a year earlier. Net loss was $42.484 million, including $16.054 million from discontinued operations; continuing-operations net loss was $26.430 million. Operating cash flow was $14.625 million, versus $95,000 a year earlier.
Two GPU services agreements have three-year committed terms and $2.7 billion in aggregate contracted revenue. Deployments are partly subject to financing and customary conditions and milestones. The company is contractually committed to approximately $2.3 billion in project capital expenditures during the 12-month look-forward period, and $2.0 billion in purchase obligations are expected to be paid within one year. ChronoScale recorded a $14.126 million impairment loss related to the Legacy Ekso business, whose sale closed September 30, 2026.
A working-capital deficit of approximately $70.5 million as of August 31, 2026 raised substantial doubt about going concern. Management concluded its plans were probable to be implemented within the 12-month look-forward period and would provide sufficient liquidity to fund project-related capital outlays and maintain run-rate operations, alleviating that doubt.